Smoking Linked to Higher Rate of Psoriasis: Study

HomeNewsSmoking Linked to Higher Rate of Psoriasis: Study

March 2, 2012   Smokers are at higher risk of developing the autoimmune skin condition psoriasis than nonsmokers, a new study finds, possibly because smoking pushes the body’s immune system into overdrive, one expert suggests. The research doesn’t directly prove that smoking causes psoriasis, and the wide majority of smokers would avoid developing the condition even if they faced an increased risk. Still, the findings provide yet another reason for smokers to drop the habit, said study co-author Dr. Abrar Qureshi, an assistant professor of dermatology at Harvard Medical School. “It behooves us even more to advise individuals who are smoking to quit,” he said, especially because psoriasis itself is linked to higher risks of diabetes and heart attacks.

For More Information:
http://www.healthfinder.gov/news/newsstory.aspx?Docid=662374&source=govdelivery

Mar 06, 2012
Report: Tobacco Companies and Convenience Stores Partner to Market Tobacco Products
Read the full story Mar 06, 2012
Obama Administration Appeals Ruling on Tobacco Graphic Warning Labels
Read the full story Mar 06, 2012
Study: Broad Anti-Smoking Vaccination Not Worth the Cost
Read the full story Mar 05, 2012
Smokeless Tobacco Use By Miami Teens Up 69 Percent: Study
Read the full story

Complete the form below to subscribe to the ActionToQuit listserv. Join the conversation about tobacco control policy and receive weekly updates.

Subscribe to the RSS feed to get notification of key dates.

View the original article here

Nicotinell Regular Strength Nicotine Gum Fruit Flavour 96 pieces

Nicotinell fruit flavour gum provides an &#101&#102&#102&#101&#99&#116&#105&#118&#101 aid to combat the unpleasant withdrawal &#115&#121&#109&#112&#116&#111&#109&#115 &#99&#97&#117&#115&#101&#100 &#98&#121 giving &#117&#112 smoking. Nicotinell 2mg &#103&#117&#109 is particularly &#117&#115&#101&#102&#117&#108 when &#115&#101&#118&#101&#114&#101 &#119&#105&#116&#104&#100&#114&#97&#119&#97&#108 &#115&#121&#109&#112&#116&#111&#109&#115 are experienced. Do not exceed &#116&#104&#101 stated dose.

Sale Price:£9.95

Read More

[amazon-product-reviews]

10 X Herbal Cigarette Holder Cig Filter Tips Reduce Tar, Nicotine, Carbon.

Herb micro filter contains extracts &#109&#111&#114&#101 &#116&#104&#97&#110 10 medicinal &#112&#108&#97&#110&#116&#115 including licorice, madder, primrose &#97&#110&#100 &#111&#116&#104&#101&#114&#115 to &#104&#101&#108&#112 &#109&#97&#107&#101 &#121&#111&#117&#114 cigarette tase &#109&#105&#108&#100.&#10&#10&#72&#101&#114&#98 extracts and &#103&#114&#101&#101&#110 tea flavonoid remove obnoxious smell in cigarette smoke and &#114&#101&#116&#97&#105&#110 aroma

Sale Price:£3.49

Read More

[amazon-product-reviews]

Many Americans Support Lower Nicotine Levels in Cigarettes

HomeNewsMany Americans Support Lower Nicotine Levels in Cigarettes

February 22, 2012   Most American adults support reducing nicotine in cigarettes to prevent people, especially children, from becoming addicted to smoking, a new study finds. Researchers surveyed 511 nonsmokers and 510 smokers aged 18 and older and found that, overall, two-thirds supported reducing nicotine levels in cigarettes to nonaddictive levels. The study also found that 77 percent (81 percent of nonsmokers and 74 percent of smokers) would support lowering the amount of nicotine in cigarettes to nonaddictive levels if doing so would reduce the number of children who became addicted to cigarettes.

For More Information:
http://health.usnews.com/health-news/news/articles/2012/02/20/many-americans-support-lower-nicotine-levels-in-cigarettes

Feb 24, 2012
Consumers Switching Between Tobacco Types
Read the full story Feb 24, 2012
Daytona Speedway to Ban Smoking
Read the full story Feb 23, 2012
More Troops on Smokeless Tobacco After Deployment
Read the full story Feb 23, 2012
Physicians Lack Confidence in Their Ability to Counsel Cancer Patients to Quit Smoking
Read the full story

Complete the form below to subscribe to the ActionToQuit listserv. Join the conversation about tobacco control policy and receive weekly updates.

Subscribe to the RSS feed to get notification of key dates.

View the original article here

Smoke Free Areas Outside Bars Could Stamp Out “Social Smoking”

HomeNewsSmoke Free Areas Outside Bars Could Stamp Out “Social Smoking”

February 21, 2012   A smoking ban in areas immediately outside bars could help curb “social smoking” because this type of smoking tends to go hand in hand with drinking, suggests a small qualitative study published in Tobacco Control. The international evidence suggests that while the overall prevalence of smoking has decreased, social smoking—smoking intermittently or only in given situations—has increased among young adults. Social smokers are not included in the statistics on smoking nor targeted by cessation programs, but they may progress to daily smoking relatively easily. In-depth interviews with social smokers revealed that drinking alcohol prompted cravings for a cigarette, which they wouldn’t otherwise experience. Most participants strongly backed a proposal to mandate smoke free areas outside bars, indicating that it would help them cut down or stop smoking.

For More Information:
http://www.onmedica.com/newsarticle.aspx?id=561a6f27-ddc0-4528-82e9-8ae79b12c807

Feb 24, 2012
Consumers Switching Between Tobacco Types
Read the full story Feb 24, 2012
Daytona Speedway to Ban Smoking
Read the full story Feb 23, 2012
More Troops on Smokeless Tobacco After Deployment
Read the full story Feb 23, 2012
Physicians Lack Confidence in Their Ability to Counsel Cancer Patients to Quit Smoking
Read the full story

Complete the form below to subscribe to the ActionToQuit listserv. Join the conversation about tobacco control policy and receive weekly updates.

Subscribe to the RSS feed to get notification of key dates.

View the original article here

More Troops on Smokeless Tobacco After Deployment

HomeNewsMore Troops on Smokeless Tobacco After Deployment

February 23, 2012   U.S. troops sent to Iraq or Afghanistan are more likely to start a smokeless tobacco habit than their comrades who stay home—especially if they see combat, according to a study published in the journal Addiction. It is not clear why some troops take up smokeless tobacco after deployment, but researchers suspect that stress is involved. The risk was higher in troops who were exposed to combat or who were deployed multiple times. Troops with post-traumatic stress disorder (PTSD) also had an increased risk. According to the authors, those different levels of deployment can be seen as stand-ins for different levels of stress. Past studies have found that while tobacco use in the military is declining, it’s still higher when compared to the U.S. public as a whole. In 2005, almost 15 percent of military personnel said they’d used smokeless tobacco in the past year—versus just three percent of Americans overall.

For More Information:
http://www.reuters.com/article/2012/02/22/us-troops-smokeless-idUSTRE81L1KZ20120222

Feb 24, 2012
Consumers Switching Between Tobacco Types
Read the full story Feb 24, 2012
Daytona Speedway to Ban Smoking
Read the full story Feb 23, 2012
More Troops on Smokeless Tobacco After Deployment
Read the full story Feb 23, 2012
Physicians Lack Confidence in Their Ability to Counsel Cancer Patients to Quit Smoking
Read the full story

Complete the form below to subscribe to the ActionToQuit listserv. Join the conversation about tobacco control policy and receive weekly updates.

Subscribe to the RSS feed to get notification of key dates.

View the original article here

Consumers Switching Between Tobacco Types

HomeNewsConsumers Switching Between Tobacco Types

February 24, 2012   Altria Group Inc. is seeing tobacco users switch between multiple forms of tobacco more often, vice chairman Dave Beran said while participating in the Consumer Analyst Group of New York (CAGNY) conference, reported Reuters. Today’s smokers are more open to trying different types of tobacco than smokers of previous generations, and Altria is working on new products to entice consumers who want a change from cigarettes, Beran told analysts and investors at the conference held in Boca Raton, Fla., this week. Altria, whose other products include Skoal and Copenhagen smokeless tobacco and Black & Mild cigars, has seen a shift in tobacco usage in the United States.

For More Information:
http://www.cspnet.com/news/tobacco/articles/consumers-switching-between-tobacco-types

Feb 24, 2012
Consumers Switching Between Tobacco Types
Read the full story Feb 24, 2012
Daytona Speedway to Ban Smoking
Read the full story Feb 23, 2012
More Troops on Smokeless Tobacco After Deployment
Read the full story Feb 23, 2012
Physicians Lack Confidence in Their Ability to Counsel Cancer Patients to Quit Smoking
Read the full story

Complete the form below to subscribe to the ActionToQuit listserv. Join the conversation about tobacco control policy and receive weekly updates.

Subscribe to the RSS feed to get notification of key dates.

View the original article here

Nicorette Chewing Gum 4mg Freshfruit – 105 Pieces

Nicorette® Gum &#97&#108&#108&#111&#119&#115 you to &#97&#99&#116&#105&#118&#101&#108&#121 control &#104&#111&#119 much nicotine you use and when &#121&#111&#117 &#117&#115&#101 it. &#73&#116 &#105&#115 available in &#100&#105&#102&#102&#101&#114&#101&#110&#116 strengths, Full &#83&#116&#114&#101&#110&#103&#116&#104 &#52&#109&#103 Gum and &#76&#111&#119 Strength 2mg Gum, so it is important to choose the &#99&#111&#114&#114&#101&#99&#116 strength to &#115&#117&#105&#116 your indiv

Sale Price:£13.00

Read More

[amazon-product-reviews]

Less Addictive Cigarettes Preferred By Smokers

Editor’s Choice
Academic Journal
Main Category: Smoking / Quit Smoking
Article Date: 20 Feb 2012 – 9:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

4 starsnot yet rated
Results from an International Tobacco Control (ITC) United States Supplemental Survey, published recently in the journal BMC Public Health , reveal that smokers strongly favor decreasing the addictiveness of cigarettes.

Lead investigator Andrew Hyland, PhD, Chair of the Department of Health Behavior at the Roswell Park Cancer Institute (RPCI), and his team, surveyed 678 smokers between November 2009 and January 2010 on their attitudes and beliefs about the Family Smoking Prevention and Tobacco Control Act (FSPTCA). In 2009, the Act was signed into law, authorizing the U.S. Food & Drug Administration (FDA) authority to control the manufacturing, marketing and sale of tobacco products, with a mandate to reduce tobacco-related disease and death.

Dr. Hyland explained:

“These baseline data were collected shortly after passage of the FDA law and prior to enactment of specific regulatory measures. These initial levels of support or opposition for specific policy measures are useful to inform policy development and highlight the need to continue to educate smokers and the public at large about the purpose behind the regulations.”

The survey findings revealed, that: 71% of smokers did not know that the FDA is authorized to regulate tobacco. 67% of smokers are in favor of reducing nicotine levels in cigarettes – if nicotine was available in a non-cigarette form. 67% of smokers reported supporting banning cigarette advertising, promotion, and marketing activities. 41% of smokers reported they would agree to a law that would ban additives and flavoring that make cigarettes less harsh.Dr. Hyland comments:

“To date, little is known about the attitudes toward the FDA’s new role in regulating tobacco products. Our research found that most smokers were supportive of efforts to make tobacco products less addictive, to ban advertising, and to better inform the public about health risks.”

The ITC United States Survey started in 2002 and has been conducted almost every year in conjunction with ITC surveys in Canada, United Kingdom, and Australia, who are part of the global ITC Project. The project performs similar surveys in over 20 countries, which combined, account for over half of the world’s population, in order to assess the affects of tobacco control policies, including warning pictures, higher taxes on tobacco products, advertising and promotion bans as well as smoke-free laws.

Dr. Hyland states:

“We are in the process of comparing our data on support for tobacco-control policies in the U.S. to support what we’ve found in other countries. This will allow us to understand tobacco use and the potential of FDA policies to reduce tobacco use not only here in the U.S. but throughout the world.”

Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our smoking / quit smoking section for the latest news on this subject. “Smokers’ reactions to FDA regulation of tobacco products: Findings from the 2009 ITC United States Survey” Brian V Fix et al.
BMC Public Health 2011, 11:941 doi:10.1186/1471-2458-11-941 Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Petra Rattue. “Less Addictive Cigarettes Preferred By Smokers.” Medical News Today. MediLexicon, Intl., 20 Feb. 2012. Web.
26 Feb. 2012. APA

Please note: If no author information is provided, the source is cited instead.


posted by Mike Morgan on 20 Feb 2012 at 9:43 am

Electronic cigarettes are another option to avoid tobacco and reduce nicotine

| post followup | alert a moderator |


posted by Mike on 20 Feb 2012 at 10:29 am

I am not surprised the many self-hating smokers who want to quit support ways to possibily make quittting easier. But survey participants were probably not told that an ad ban is illegal here, as well as making cigarettes less addictive by reducing nicotine might lead to smoking more or buying more “full hit” cigarettes from a black market.

| post followup | alert a moderator |


posted by Dr. J on 20 Feb 2012 at 12:52 pm

I would hazard a guess that heroin users would like to decrease the addictiveness of heroin, yes?

If you want to not be addicted to a substance that is addictive, don’t use it, duh!

| post followup | alert a moderator |


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


View the original article here

In Patients With Spinocerebellar Ataxia Type 3, Smoking Cessation Drug Improves Walking Function

Main Category: Neurology / Neuroscience
Also Included In: Smoking / Quit Smoking
Article Date: 24 Feb 2012 – 1:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
1 starnot yet rated
A nicotinic drug approved for smoking cessation significantly improved the walking ability of patients suffering from an inherited form of ataxia, reports a new clinical study led by University of South Florida researchers.

The randomized controlled clinical trial investigated the effectiveness of varenicline (Chantix®) in treating spinocerebellar ataxia type 3, or SCA3. The findings were published online earlier this month in Neurology, the journal of the American Academy of Neuroscience.

Lead author Dr. Theresa Zesiewicz and colleagues at the USF Ataxia Research Center collaborated with researchers from Beth Israel Deaconess Medical Center in Boston, MA, and from the David Geffen School of Medicine at UCLA in Los Angeles, CA.

Spinocerebellar ataxia impairs the brain and spinal cord causing progressive difficulty with coordination of movements, including walking. The uncoordinated movements, or ataxia, is a neurological symptom with no treatment or cure and can lead to serious fall-related injuries.

“This is the first clinical trial in patients with ataxia showing that nicotinic acetycholine agonists improve symptoms associated with the ability to stand straight and walk,” said Dr. Zesiewicz, professor of neurology and director of the USF Ataxia Research Center. “Patients receiving varenicline could walk with more ease, with less help and faster than those in the placebo group.”

The double-blind multicenter study evaluated 20 adult patients with genetically confirmed SCA3. Half the patients received 1 mg. of varenicline twice a day, and the other half received placebo. At the end of the eight-week study, patients taking varenecline performed significantly better on measures of gait, stance, rapid alternating movements and a timed 25-foot walk than those who did not. The drug was fairly well tolerated, with mild nausea being the most common side effect.

The study authors suggest that varenicline’s ability to improve ataxia may be associated with the drug’s ability to act at several different sites in the brain affected by nicotine.

Study co-author Lynn Wecker, PhD, a distinguished research professor at USF Health, is investigating the cellular and molecular mechanisms mediating the effects of varenicline and other nicotinic agonists. Dr. Wecker and colleagues, supported by a five-year grant funded by the National Institute of Neurological Disorders and Stroke, have shown that several drugs affecting neuronal nicotinic receptors improve gait and balance in an animal model of SCA3.

Further preclinical research is needed to understand how nicotinic acetylcholine agonists improve ataxia, and larger clinical studies with more patients are needed to identify other neurodegenerative diseases that may benefit from nicotinic medications, the authors conclude.

Article adapted by Medical News Today from original press release. Click ‘references’ tab above for source.
Visit our neurology / neuroscience section for the latest news on this subject. The study was supported by the National Ataxia Foundation and the Bobby Allison Ataxia Research Center.
Citation: “A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3,”T.A. Zesiewicz, MD, FAAN; P.E. Greenstein, MB, BCh; K.L. Sullivan, MSPH; L. Wecker, PhD; A. Miller, BS; I. Jahan, MD; R. Chen, MD and S.L. Perlman, MD, FAAN, Neurology, published online before print Feb. 8, 2012. DOI: 10.1212/WNL.0b013e318247cc7a.
University of South Florida (USF Health) Please use one of the following formats to cite this article in your essay, paper or report:

MLA

University of South Florida (USF Health). “In Patients With Spinocerebellar Ataxia Type 3, Smoking Cessation Drug Improves Walking Function.” Medical News Today. MediLexicon, Intl., 24 Feb. 2012. Web.
26 Feb. 2012. APA

Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


View the original article here